Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-19T22:46:22.887Z Has data issue: false hasContentIssue false
  • English
  • Français

Molecular Typing of Imipenem-Resistant Acinetobacter baumannii-calcoaceticus Complex in a Singapore Hospital Where Carbapenem Resistance Is Endemic

Published online by Cambridge University Press:  02 January 2015

Thean Yen Tan ,
Karen Poh  and
Siew Yong Ng
Thean Yen Tan*
Affiliation:
Department of Microbiology, Laboratory Medicine Services, Changi General Hospital, Singapore
Karen Poh
Affiliation:
Department of Microbiology, Laboratory Medicine Services, Changi General Hospital, Singapore
Siew Yong Ng
Affiliation:
Department of Microbiology, Laboratory Medicine Services, Changi General Hospital, Singapore
*
Laboratory Medicine Services, Changi General Hospital, 2 Simei St. 3, Singapore 529889 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To investigate the molecular epidemiology of carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex isolates in a tertiary care hospital where the prevalence of carbapenem resistance among these organisms is high.

Design.

The study was a prospective, observational study performed during an 8-month period (May 1 through December 31, 2004). A. baumannii isolates recovered from all clinical samples during the study period were included in the study. Antibiotic susceptibility testing was performed using the disk diffusion method, and all carbapenem-resistant strains were typed by a polymerase chain reaction-based typing method.

Setting.

An 800-bed hospital in Singapore.

Results.

More than half of recovered isolates were clonally unrelated, with the remaining isolates grouped into 4 genotypes.

Conclusions.

The results of the study suggest that the high prevalence of carbapenem resistance among Acinetobacter organisms in this institution is not caused by the spread of a predominant clone and that other factors may need to be investigated.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 8 , August 2007 , pp. 941 - 944
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Garcia-Garmendia, JL, Ortiz-Leyba, C, Garnacho-Montero, J, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 2001;33:939–946.Google Scholar
2. Higgins, PG, Wisplinghoff, H, Stefanik, D, Seifert, H. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. An-timicrob Agents Chemother 2004;48:1586–1592.CrossRefGoogle ScholarPubMed
3. Afzal-Shah, M, Livermore, DM. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 1998;41:576–577.CrossRefGoogle ScholarPubMed
4. Villegas, MV, Hartstein, AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24:284–295.CrossRefGoogle ScholarPubMed
5. Acinetobacter baumannii infections among patients at military medical facilities treating injured US service members, 2002-2004. MMWR Morb Mortal Wkly Rep 2004;53:1063–1066.Google Scholar
6. Aygun, G, Demirkiran, O, Utku, T, et al. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 2002;52:259–262.Google Scholar
7. Seifert, H, Dijkshoorn, L, Gerner-Smidt, P, Pelzer, N, Tjernberg, I, Vanee-choutte, M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997;35:2819–2825.Google Scholar
8. Bergogne-Berezin, E, Towner, KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148–165.CrossRefGoogle ScholarPubMed
9. Quale, J, Bratu, S, Landman, D, Heddurshetti, R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003;37:214–220.CrossRefGoogle ScholarPubMed
10. Rhomberg, PR, Fritsche, TR, Sader, HS, Jones, RN. Clonal occurrences of multidrug-resistant gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004). Diagn Microbiol Infect Dis 2006;54:249–257.CrossRefGoogle ScholarPubMed
11. Schreckenberger, PC, Daneshvar, MI, Weyant, RS, Hollis, DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In: Murray, PR, Baron, EJ, Jorgensen, JH, Pfaller, MA, Yolken, RH, eds. Manual of Clinical Microbiology. 8th ed. Washington, DC: ASM Press; 2003:749–779.Google Scholar
12. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. 25th ed. Wayne, PA: CLSI; 2005:M100-S15,Google Scholar
13. Gerner-Smidt, P, Tjernberg, I, Ursing, J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991;29:277–282.Google Scholar
14. Grundmann, HJ, Towner, KJ, Dijkshoorn, L, et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 1997;35:3071–3077.Google Scholar
15. Van de Peer, Y, De Wachter, R. TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment. Comput Appl Biosci 1994;10:569–570.Google ScholarPubMed
16. Link, W, Dixens, C, Singh, M, Schwall, M, Mekhinger, AE. Genetic diversity in European and Mediterranean fava bean germ plasm revealed by RAPD markers. Theor Appl Genet 1995;90:27–32.CrossRefGoogle Scholar
17. Harris, AD, McGregor, JC, Furano, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006;43(suppl 2):S57–S61.CrossRefGoogle ScholarPubMed
18. Manuel, RJ, Shin, GY, Farrag, N, Holliman, R. Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital. J Antimicrob Chemother 2003;52:141–142.CrossRefGoogle Scholar
19. Harbarth, S, Harris, AD, Carmeli, Y, Samore, MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001;33:1462–1468.CrossRefGoogle ScholarPubMed
20. Lipsitch, M, Samore, MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002;8:347–354.Google Scholar